BCIQ Profiles

Company Profile Report
0721 Master protocols data
BioCentury & Getty Images

Product Development

Mastering master protocols: lessons from COVID

RECOVERY was the outlier rather than the norm, but the failures could shape how these trials should operate next time

RECOVERY was the outlier rather than the norm, but the failures could shape how these trials should operate next time

Jul 21, 2021 | 7:53 PM GMT

Despite the success of the U.K.’s RECOVERY trial, master protocol trials on the whole were not the force for rapid, efficient drug development during COVID-19 that they should have been. But the failures have been as instructive, pointing to what works and doesn’t, and setting the ground rules for a network of such trials to be deployed when disaster next strikes. 

BioCentury’s analysis of 16 master protocol studies initiated since the start of the pandemic

Read the full 1320 word article

How to gain access

Continue reading with a
two-week free trial.